Y.S.P. Southeast Asia Holding Berhad (KLSE:YSPSAH)

Market Cap	312.06M
Revenue (ttm)	368.66M
Net Income (ttm)	26.69M
Shares Out	141.84M
EPS (ttm)	0.19
PE Ratio	11.70
Forward PE	n/a
Dividend	0.11 (5.00%)
Ex-Dividend Date	Jun 25, 2025

Volume	300
Average Volume	32,265
Open	2.200
Previous Close	2.200
Day's Range	2.200 - 2.200
52-Week Range	1.980 - 3.180
Beta	0.05
RSI	58.19
Earnings Date	May 22, 2025

About KLSE:YSPSAH

Y.S.P. Southeast Asia Holding Berhad, together with its subsidiaries, manufactures and trades in generic drugs. The company operates through three segments: Manufacturing, Trading, and Investment Holding. It manufactures, sells, imports, exports, trades in, and distributes pharmaceutical and veterinary products, pharmaceutical fine chemicals, raw material, health food products, and medical devices. The company also manufactures aquatic, cosmetic, and biotechnology products, as well as traditional herbal medicines, food supplements, over-the-cou...

• Industry: Pharmaceutical Preparations
• Founded: 1987
• Employees: 1,381
• Stock Exchange: Bursa Malaysia
• Ticker Symbol: YSPSAH

Financial Performance

In 2024, KLSE:YSPSAH's revenue was 368.66 million, an increase of 3.85% compared to the previous year's 355.00 million. Earnings were 26.69 million, a decrease of -28.48%.